- Our Doctors
- A/Prof Stephen Della-Fiorentina
A/Prof. Stephen Della-Fiorentina OAM
OAM MBBS Hons FRACP, Medical Oncologist
Languages spoken
English
Overview
Centres
Clinical interests
A/Prof Stephen Della-Fiorentina is a senior medical oncologist in South West Sydney and has been offering high-quality cancer care to the population in the Local Government Areas of Campbelltown, Camden, Wollondilly, and the Southern Highlands for over 25 years.
He is the current Clinical Director of Cancer Services at South West Sydney Local Health District and was the Foundation Director of the Macarthur Cancer Therapy Centre at Campbelltown Hospital - a leader in patient satisfaction - which ranked as the best public cancer centre for six consecutive years.
A/Prof Della-Fiorentina is a pioneer in the development of the electronic cancer medical record in Australia and a co-chair of the Protocol Build Committee. He is also a member of the Cancer Working Group for the development of the Single Digital Patient Record in NSW Health, scheduled for implementation in 2026-2027.
He holds an appointment with Western Sydney University and the University of Wollongong and is an accredited supervisor of oncology trainees.
He has extensive experience in phase 1-3 clinical trials in multiple tumour sites. In 2022, he was awarded an Order of Australia Medal for his services to oncology.
Clinical interests
Clinical interest in Medical Oncology – Breast, Genitourinary, Lung
Research interests
Professional memberships
- Royal Australasian College of Physicians
- Medical Oncology Group of Australia
- Australian Salaried Medical Officer Federation
Publications
- Carson, E. K., Dhillon, H. M., Vardy, J. L., Brown, C., Nunes-Zlotkowski, K. F., Della-Fiorentina, S., ... & Kiely, B. E. (2024). Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study. Supportive Care in Cancer, 32(6), 375.
- Grimison, P., Mersiades, A., Kirby, A., Tognela, A., Olver, I., Morton, R. L., ... & Stockler, M. R. (2024). Oral cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Final results of a randomized, placebo-controlled, phase II/III trial. Journal of Clinical Oncology, 42(34), 4040-4050.
- Pillippu Hewa, C., Della-Fiorentina, S., Haghighi, K., Chua, W., & Kok, P. S. (2024). Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia. Frontiers in Urology, 4, 1309532.
- Rincones, O., Bamgboje-Ayodele, A., Arnold, A., Delaney, G. P., Durcinoska, I., Avery, S., ... & Girgis, A. (2023). Cancer Care Team’s Management of Clinical Alerts Generated by Electronically Collected Patient Reported Outcomes: We Could Do Better. International Journal of Environmental Research and Public Health, 20(3), 2001.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.